UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B
admin Belgian biopharmaceutical giant UCB announced Friday a definitive agreement to acquire Neurona Therapeutics, a privately...
admin
Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
The biopharmaceutical landscape witnessed a flurry of significant developments this past week, ranging from the...
We’re partnering internationally to create far-reaching impact for kids with cancer.
CureSearch for Children’s Cancer, a leading global non-profit focused on accelerating the development of pediatric...
CureSearch Awards $2 Million for Innovative Pediatric Brain Cancer Clinical Trial Led by Washington University Researchers
St. Louis, Missouri — CureSearch for Children’s Cancer has officially announced a $2 million funding...
Honoring the Legacy of Luke Getchell: The Critical Imperative for Advancing Pediatric Acute Myeloid Leukemia Research and Treatment Protocols
The diagnosis of pediatric cancer represents one of the most significant challenges in modern medicine,...
February Marks National Cancer Prevention Month Amidst Alarming Preventable Cancer Statistics
February is recognized annually as National Cancer Prevention Month, a critical period for individuals and...
Kailera Therapeutics Secures $625 Million in Landmark Biotech IPO, Igniting Competition in the Obesity Drug Market
Kailera Therapeutics, a formidable new entrant in the pharmaceutical landscape poised to challenge industry giants...
Advancing the Frontier of Ewing Sarcoma Research Through Philanthropic Investment and Innovative Science
Ewing sarcoma, a rare and aggressive form of bone and soft tissue cancer that primarily...
Celebrating Frank Gioscia’s Remarkable Journey for Childhood Cancer Research
The landscape of philanthropic endeavor is often defined by steady, incremental progress, but rarely does...
A Rare Cancer and the Clinical Trial That Saved Her Life
Adrienne Skinner’s journey through a harrowing cancer diagnosis to a life-affirming recovery stands as a...
